Directory → Metaboliki → Lipid means → Fibrata → Gemfibrosil
This page is translated automatically with a help of Google Translate

Gemfibrosil

See also Gemfibrozil

Roman name

Gemfibrosil

Of drugs

Received as a result of a derivative klofibrata with less toxicity. Gemfibrosil malotoksicnam has yet highly gipolipidemicakim (reduce the lipids in the blood) means reducing the LPONP (LDL very low density) in the blood of patients with гипертриглицеридемие й (elevated triglycerides in the blood) is not responding to treatment diet and other lipid means. In addition, increases concentration LPVP (high density polyethylene). 1

Storage conditions

In a cool place.

Indications for use

Assign patients гипертриглицеридемие й in the resistance to therapeutic diets and other gipolipidemicakim means. In gipergilomikronemii (increased content in the blood hilomik-ronov / neutral particle diameter fat one Mkmd from family lipoproteinlipaza deficit (enzyme destroys lipoprotein), a product of little use.

Dosing and Administration

Assign an adult to 0,3-0,45 g twice a day (30 minutes before breakfast and dinner). Full medical effects developed in 3-4 weeks.

Side-Effects

Gemfibrosil usually well tolerated. There gastrointestinal disorders (pain in the abdomen, nausea, diarrhea). In the rare cases where a small anaemia (decrease in hemoglobin in the blood), lakopenia (to reduce blood in the blood). Like klofibratu (but less) can have biliary stones.

Contraindications

Contraindications patients with diseases of the gall bladder. The agent is not appointed women and children.

Form of

The capsules 0.3 g (300 mg); Tablets, coated liner to 0.45 and

All products of this group

0